| 今开：0.1301 | 昨收：0.13 |
| 最高：0.1375 | 最低：0.114 |
| 涨停价：0.0 | 跌停价：0.0 |
| 总市值：5758313.0 |
Avenue Therapeutics(ATXI)01-25 05:15
$Avenue Therapeutics(ATXI)$ S-3 Registration statement under Securities Act of 1933 Accession Number: 0001104659-24-006250 Act: 33 Size: 342 KB 网页链接查看全文
Avenue Therapeutics(ATXI)02-24 05:25
$Avenue Therapeutics(ATXI)$ 8-K Current report, items 5.03 and 9.01 Accession Number: 0001104659-24-027037 Act: 34 Size: 207 KB 网页链接查看全文
Avenue Therapeutics(ATXI)03-19 04:25
$Avenue Therapeutics(ATXI)$ 10-K Annual report [Section 13 and 15(d), not S-K Item 405] Accession Number: 0001437749-24-008294 Act: 34 Size: 7 MB 网页链接查看全文
Avenue Therapeutics(ATXI)03-15 19:25
$Avenue Therapeutics(ATXI)$ 8-K Current report, item 8.01 Accession Number: 0001104659-24-034774 Act: 34 Size: 204 KB 网页链接查看全文
Avenue Therapeutics(ATXI)03-19 05:05
$Avenue Therapeutics(ATXI)$ DEF 14C Other definitive information statements Accession Number: 0001104659-24-035578 Act: 34 Size: 112 KB 网页链接查看全文
Avenue Therapeutics(ATXI)04-18 04:15
$Avenue Therapeutics(ATXI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-24-048303 Size: 5 KB 网页链接查看全文
Avenue Therapeutics(ATXI)04-18 04:15
$Avenue Therapeutics(ATXI)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-24-048307 Act: 34 Size: 52 KB 网页链接查看全文
Avenue Therapeutics(ATXI)03-19 04:15
$Avenue Therapeutics(ATXI)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001104659-24-035544 Act: 34 Size: 287 KB 网页链接查看全文
Avenue Therapeutics(ATXI)01-29 21:05
$Avenue Therapeutics(ATXI)$ DEF 14C Other definitive information statements Accession Number: 0001104659-24-007466 Act: 34 Size: 142 KB 网页链接查看全文
产业链观察2023-03-02 21:25
#药闻简讯# $Avenue Therapeutics(ATXI)$ 与AnnJi制药公司达成了AJ201的独家许可协议，AJ201是一种一流的临床资产，目前正在美国进行1b/2a期研究，用于治疗脊柱和球状肌肉萎缩症，也称为肯尼迪病。
根据条款，AnnJi将获得300万美元的预付款，并有权获得未来的开发、监管和商业化里程碑付款，以...查看全文
港美情报站2022-09-23 18:02
与葛兰素史克签大单！$Spero治疗(SPRO)$ 荣登妖股涨幅榜榜首
医药股历来是妖股集中营，昨日#美股# 涨幅前二的#妖股# 都是生物医药行业。昨日妖股涨幅榜榜首是SPRO，盘中最大涨幅接近300%，收盘涨幅也有167%。
消息面上，昨日，葛兰素史克和Spero Therapeutics已就tebipenem pivoxil hydrob...查看全文
格隆汇4月18日丨Avenue Therapeutics盘前涨15.65%，报1.33美元。Avenue Therapeutics周一表示，3月9日与美国FDA就开发用于治疗术后疼痛的静脉注射曲马多(IV Tramadol)举行的官方纪要表明，该机构在拟议研究方案... 网页链接
$Avenue Therapeutics(ATXI)$ SC 13D/A [Amend] General statement of acquisition of beneficial ownership Accession Number: 0001104659-22-109827 Act: 34 Size: 81 KB 网页链接
$Avenue Therapeutics(ATXI)$ 8-K Current report, item 8.01 Accession Number: 0001104659-22-109739 Act: 34 Size: 200 KB 网页链接
$Avenue Therapeutics(ATXI)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001104659-22-109231 Act: 34 Size: 90 KB 网页链接
$Avenue Therapeutics(ATXI)$ SC 13G Statement of acquisition of beneficial ownership by individuals Accession Number: 0001213900-22-064163 Act: 34 Size: 79 KB 网页链接
$Avenue Therapeutics(ATXI)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001104659-22-108589 Size: 7 KB 网页链接
$Avenue Therapeutics(ATXI)$ 8-K Current report, items 1.01, 8.01, and 9.01 Accession Number: 0001104659-22-107952 Act: 34 Size: 936 KB 网页链接
$Avenue Therapeutics(ATXI)$ 424B4 Prospectus [Rule 424(b)(4)] Accession Number: 0001104659-22-107456 Act: 33 Size: 1 MB 网页链接
$Avenue Therapeutics(ATXI)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-22-002969 Act: 33 Size: 1 KB 网页链接
$Avenue Therapeutics(ATXI)$ FWP Filing under Securities Act Rules 163/433 of free writing prospectuses Accession Number: 0001104659-22-106772 Act: 34 Size: 4 MB 网页链接
$Avenue Therapeutics(ATXI)$ S-1/A [Amend] General form for registration of securities under the Securities Act of 1933 Accession Number: 0001104659-22-106535 Act: 33 Size: 1 MB 网页链接